Infection profile of immune-modulatory drugs used in autoimmune diseases: analysis of summary of product characteristic data

OBJECTIVE: Serious infection remains a concern when prescribing immune-modulatory drugs for immune-mediated inflammatory diseases. The ‘summary of product characteristics’ (SmPCs) provide information on adverse events for example, infections, from clinical trials and postmarketing pharmacovigilance....

Descripción completa

Detalles Bibliográficos
Autores principales: Dey, Mrinalini, Bechman, Katie, Zhao, Sizheng, Fragoulis, George E, Smith, Catherine, Cope, Andrew, Nikiphorou, Elena, Hyrich, Kimme L, Galloway, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685189/
https://www.ncbi.nlm.nih.gov/pubmed/36418084
http://dx.doi.org/10.1136/rmdopen-2022-002621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685189/
https://www.ncbi.nlm.nih.gov/pubmed/36418084
http://dx.doi.org/10.1136/rmdopen-2022-002621

Ejemplares similares